Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
Clinical trial NCT07487168 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07487168
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-03-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.